HologenAI
AI models for healthcare based on real-world data.
Hologen Limited specialises in building AI models from real-world data for use in healthcare.
Their technology can be applied to Phase 2 and 3 clinical trials to enable accurate quantification of therapeutic effects, and illuminates disease mechanisms opaque to conventional models, revealing new therapeutic and commercial opportunities.
The HologenAI journey so far:
- Founded in 2025
Dr. Caitriona O'Rourke (Away from office)
Senior Business Manager
Dr O’Rourke joined us in 2018, having worked as a research associate within UCL on several diverse life science / pharmaceutical research projects covering the areas of tissue engineering, drug
delivery, regenerative medicine, biomaterials and stem cell biology.
Caitriona holds a PhD in tissue engineering from the Open University and a MSc in neuropharmacology from the National University of Galway, Ireland.